Skip to content
GERICLINICS

Flashcards · Module 34

🩸 Peripheral Vascular & Thromboembolic Disease

4 of 4 cards published · read by the site’s author on 21 November 2026

Peripheral Artery Disease (PAD) & The Ankle-Brachial Index (ABI): The stiff artery trap!

Needs clinical review

How the ABI Works:

\text{ABI} = \frac{\text{Highest Systolic BP at Ankle (DP or PT)}}{\text{Highest Systolic BP in either Arm (Brachial)}}

Diagnostic Tiers:

  • Normal: 1.00 to 1.40

  • Borderline: 0.91 to 0.99

  • Abnormal (PAD): ≤ 0.90 (high specificity ~89%, moderate sensitivity ~65% for ≥50% arterial stenosis)

  • Severe Ischemia: < 0.40 (critical limb-threatening ischemia)

The Huge Geriatric Trap: ABI > 1.40 (Non-Compressible Arteries)

In older adults with diabetes or end-stage renal disease, Mönckeberg medial calcific sclerosis turns the tibial arteries into rigid, calcified lead pipes!

  • The blood pressure cuff cannot compress the stone-hard artery, resulting in a falsely elevated ABI > 1.40!

  • 🚨 The Mistake: Believing an ABI of 1.45 means "great circulation."

  • ✅ The Correct Test: Order a Toe-Brachial Index (TBI): it detects PAD when the ankle arteries are incompressible; TBI < 0.70 is the guideline threshold.

One-Liner: An ABI ≤0.90 diagnoses PAD; in diabetic elders with calcified, non-compressible vessels (ABI >1.40), you must measure the Toe-Brachial Index (TBI <0.70 = PAD).
Sources checked (7) · 18 November 2026

Note: Incompressible ankle arteries from medial arterial calcification in diabetes or hemodialysis can yield falsely normal or elevated ABI values and underestimate PAD. (Prevalence of Peripheral Artery Disease by Ankle-Brachial and Toe-Brachial Indices and Factors Associated with Toe-Brachial Index-Defined Disease in Maintenance Hemodialysis Patients (2026))

Note: Toe-brachial index measurement detects PAD in patients with incompressible ankle arteries due to medial arterial calcification, most frequently associated with diabetes. (Screening for Peripheral Artery Disease Using an Automated Four-Limb Blood Pressure Monitor Equipped with Toe-Brachial Index Measurement (2023))

Abdominal Aortic Aneurysm (AAA) Screening & Rupture Risk

Needs clinical review

The Silent Killer:

Most AAAs cause no symptoms until they rupture, and the risk of death with rupture is as high as 81%!

The USPSTF Screening Recommendation:

  • One-time screening ultrasound for abdominal aortic aneurysm in:

    Men aged 65 to 75 who have EVER smoked (≥100 lifetime cigarettes).

Size Cutoffs and Interventions:

Aneurysm DiameterRupture RiskManagement Protocol
< 4.0 cmLowSurveillance ultrasound every 3 years (3.0–3.9 cm)
4.0 to 5.4 cmModerateSurveillance ultrasound every 6 to 12 months
≥ 5.5 cm (or rapid expansion >0.5 cm in 6 months)HIGH: about 9–10%/year at 5.5–6.9 cm, 32.5% at ≥7 cm🚨 Elective Repair (EVAR or open surgery)
Women cutoffLower threshold≥ 5.0 cm (women rupture at smaller diameters!)

EVAR in Frail Elders:

Endovascular Aneurysm Repair (EVAR) places a stent-graft via the femoral arteries, avoiding cross-clamping and laparotomy, with much lower 30-day perioperative mortality.

One-Liner: One-time AAA ultrasound is indicated for men 65–75 who ever smoked; elective repair is indicated at ≥5.5 cm (or ≥5.0 cm in women).
Sources checked (8) · 18 November 2026

Note: USPSTF gives a Grade C recommendation to selectively offer screening to men aged 65 to 75 years who have never smoked, Grade D against routine screening in women who have never smoked and have no family history of AAA, and an I statement for women aged 65 to 75 years who have ever smoked or have a family history. (Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement (2019))

Note: In EVAR-1, EVAR achieved lower 30-day mortality (1.8% vs 4.3% for open repair) with comparable long-term outcomes up to 15 years, at the cost of a 15-20% reintervention burden and lifelong imaging surveillance. ([Abdominal aortic aneurysms: diagnosis, risk stratification and treatment strategies] (2026))

Deep Vein Thrombosis & Pulmonary Embolism: The Age-Adjusted D-Dimer

Needs clinical review

The Problem with D-Dimer in Elders:

In young patients, a standard D-dimer cutoff of 500 μg/L safely rules out DVT and PE. But in healthy older adults, baseline D-dimer levels naturally rise due to age-related endothelial activation and inflammaging.

  • Among patients aged ≥75 with suspected PE, the 500 µg/L cutoff ruled out PE in only 6.4%!

  • Result: with a 500 µg/L cutoff, most older patients with suspected PE go on to CT pulmonary angiography.

The Solution: Age-Adjusted D-Dimer Cutoff (for Age > 50)

\text{Age-Adjusted D-Dimer Cutoff} = \mathbf{\text{Age (years)}} \times 10 \ μ\text{g/L}

Examples:

  • At age 70: Cutoff is 700 μg/L

  • At age 85: Cutoff is 850 μg/L

Clinical Utility (The ADJUST-PE Trial):

In patients with non-high pretest clinical probability, the age-adjusted formula increased PE exclusion from 28.2% to 39.8% overall—and from 6.4% to 29.7% (+23.3%) in patients aged ≥75 years—with a 3-month VTE failure rate of only 0.3% (1 of 331 patients).

One-Liner: In patients over 50 with non-high (low or intermediate) pretest clinical probability, use the age-adjusted D-dimer formula (Age × 10 μg/L) to safely rule out PE without unnecessary CT scans.
Sources checked (2) · 18 November 2026

DOAC Dosing in Extreme Age, Low Weight & CKD: The Apixaban "ABC Rule"

Needs clinical review

Direct Oral Anticoagulants (DOACs) in Frail Elders:

DOACs (Apixaban, Rivaroxaban, Dabigatran, Edoxaban) cause about half the intracranial hemorrhage of warfarin (RR 0.48). But dosing must be adjusted carefully!

The Apixaban (Eliquis) "ABC Rule" for Non-Valvular A-Fib:

Standard dose is 5 mg PO BID.
Reduce the dose to 2.5 mg PO BID IF the patient meets AT LEAST 2 of the following 3 criteria (A-B-C):

  1. 🎂 A — Age: Age ≥ 80 years

  2. ⚖️ B — Body Weight: Weight ≤ 60 kg (132 lbs)

  3. 🫘 C — Creatinine: Serum Creatinine ≥ 1.5 mg/dL (133 μmol/L)

The Board Trap:

If an 82-year-old weighs 55 kg but her creatinine is 0.9 mg/dL:

  • Does she meet 2 criteria? YES! (Age ≥80 AND Weight ≤60 kg).

  • Dose = 2.5 mg BID!

  • If an 85-year-old weighs 75 kg with Cr 1.1 mg/dL, she meets only ONE criterion (Age ≥80) → keep standard dose 5 mg BID!

One-Liner: For Apixaban in A-fib, reduce dose to 2.5 mg BID only if the patient meets at least 2 of 3 criteria: Age ≥80, Weight ≤60 kg, or Creatinine ≥1.5 mg/dL.
Sources checked (5) · 18 November 2026

Note: In the same meta-analysis of 71,683 patients, DOACs significantly reduced intracranial hemorrhage and all-cause mortality compared with warfarin, but significantly increased gastrointestinal bleeding. (Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (2014))

Note: The dose-reduction rule applies to nonvalvular atrial fibrillation; acute DVT/PE treatment is 10 mg twice daily for the first 7 days followed by 5 mg twice daily. (DailyMed - ELIQUIS- apixaban tablet, film coated)